Senate Bill 2260
115th Congress(2017-2018)
Opioids and STOP Pain Initiative Act
Introduced
Introduced in Senate on Dec 21, 2017
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2260
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Opioids and STOP Pain Initiative Act
This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including:
- understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016;
- improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and
- supporting the Federal Pain Research Strategy.
NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.
December 21, 2017
12/21/2017
Read twice and referred to the Committee on Finance.
12/21/2017
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:39:05 PM